Study guide
9.1 Postpartum Haemorrhage (PPH): Definition, 4Ts, Bimanual Compression & Medical Protocols
NMC Test of Competence Part 1: Midwifery Computer-Based Test Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: NMC Framework, Autonomy & Professional Ethics
1.1 NMC Regulatory Architecture, RM Registration & The Code 1.2 Autonomous Midwifery Practice, Accountability & Delegation 1.3 Informed Consent, Capacity, Advocacy & Human Rights 1.4 Duty of Candour, Confidentiality & Clinical Documentation Human Rights, Equality, Anti-Discriminatory & Culturally Sensitive Care
2 Chapter 2: Continuity, Public Health & Perinatal Mental Health
2.1 Continuity of Carer & Physiological Midwifery Care 2.2 Public Health, Social Determinants & Health Inequalities 2.3 Perinatal Mental Health Assessment & Emergency Psychiatric Care UK Health & Social Care System, Birth Settings, Safe Staffing & Keeping Mothers and Babies Together
3 Chapter 3: Safeguarding, Vulnerable Populations & FGM
3.1 Safeguarding Children & Adults at Risk in Maternity Care 3.2 Domestic Abuse Identification, Risk Assessment & Multi-Agency Referral 3.3 FGM Mandatory Reporting, Clinical Classification & Trauma-Informed Practice
4 Chapter 4: Universal Antenatal Care & Fetal Assessment
4.1 Antenatal Care Schedule, Physiological Adaptations & Routine Investigations 4.2 Fetal Growth Surveillance, Fundal Height & Symphysis-Fundal Height (SFH) Plotting 4.3 UK National Screening Committee (UK NSC) Antenatal Screening Programmes 4.4 Antenatal Education, Birth Planning & Minor Disorders of Pregnancy Reproductive Anatomy, Genetics & Genomics, Embryology and Fetal Development
5 Chapter 5: Universal Intrapartum Care & Physiological Labour
5.1 Physiology of Normal Labour, Hormonal Regulation & Latent vs Active First Stage 5.2 Second Stage Management, Mechanisms of Normal Labour & Perineal Protection 5.3 Third Stage Management: Active vs Physiological & Examination of Placenta/Membranes 5.4 Pain Management in Labour: Non-Pharmacological & Pharmacological Analgesia
6 Chapter 6: Universal Postnatal Care & Infant Feeding
6.1 Physiological Maternal Postnatal Involution, Assessment & Recovery 6.2 Perineal Trauma Assessment, Classification (1st to 4th Degree) & Care Principles 6.3 Physiology of Lactation, Breastfeeding Support & UNICEF Baby Friendly Standards 6.4 Formula Feeding Safety, Responsive Bottle Feeding & Infant Growth Patterns Contraception & Sexual and Reproductive Health after Birth
7 Chapter 7: Newborn Assessment & Neonatal Care
7.1 Newborn Transition, Apgar Scoring, Thermoregulation & Skin-to-Skin Care 7.2 Newborn Physical Examination (NIPE 4 Core Elements) & Routine Prophylaxis 7.3 Neonatal Blood Spot Screening, Hearing Screening & Infection Prevention
8 Chapter 8: Medical & Obstetric Antenatal Complications
8.1 Pre-existing Medical Conditions in Pregnancy (Diabetes, Cardiac, Epilepsy, Renal) 8.2 Hypertensive Disorders of Pregnancy, Pre-eclampsia & Eclampsia 8.3 Antepartum Haemorrhage: Placenta Praevia, Placental Abruption & Vasa Praevia 8.4 Gestational Diabetes Mellitus (GDM): Screening, Diagnostic Criteria & Management
9 Chapter 9: Intrapartum Complications & Obstetric Emergencies
9.1 Postpartum Haemorrhage (PPH): Definition, 4Ts, Bimanual Compression & Medical Protocols 9.2 Shoulder Dystocia: Recognition, Risk Factors & HELPERR Emergency Sequence 9.3 Umbilical Cord Prolapse, Uterine Rupture & Amniotic Fluid Embolism 9.4 Maternal Sepsis, MEOWS Escalation & Maternal Resuscitation (Modified BLS/ALS)
10 Chapter 10: Fetal Compromise & Neonatal Complications
10.1 Intrapartum Fetal Heart Rate Monitoring & CTG Interpretation (NICE / FIGO) 10.2 Neonatal Resuscitation: Resuscitation Council UK NLS Algorithm 10.3 Neonatal Hypoglycaemia, Hyperbilirubinaemia & Neonatal Sepsis (NICE NG195) 10.4 Perinatal Loss, Bereavement Care & Perinatal Palliative Support
11 Chapter 11: Midwifery Pharmacology, Prescribing & Skills
11.1 Midwives Exemptions under Human Medicines Regulations 2012 & PGDs 11.2 Core Midwifery Medicines Administration & Controlled Drugs Storage/Recording 11.3 Episiotomy: Clinical Indications, Infiltration Technique & Incision Anatomy 11.4 Aseptic Non-Touch Technique (ANTT), Bladder Catheterisation & Cannulation Infection Prevention & Control, Communicable Disease Surveillance and Antimicrobial Stewardship
12 Chapter 12: Leadership, Multidisciplinary Safety & Quality
12.1 Interprofessional Team Communication, SBAR Handover & Human Factors 12.2 Incident Reporting, Root Cause Analysis & Learning from Reviews (MNSI, MBRRACE) 12.3 Midwife as Scholar, Clinical Supervisor, Leader & Escalating Safety Concerns Research Methods, Critical Appraisal, Audit & Service Evaluation Quality Improvement, Change Management, Sustainable Healthcare & Digital Practice Resilience, Wellbeing, Reflection, Human Factors & Leading Care
13 Chapter 13: Part A Numeracy & Drug Calculation Mastery
13.1 Metric Units, Conversions, Rounding & CBT Pearson VUE Numeric Answer Rules 13.2 Oral Medications, Liquid Suspensions & Solid Dose Calculations 13.3 Injectable Medicines, Dilutions, Percentages & Weight-Based Calculations 13.4 Intravenous Infusions, Flow Rates, Syntocinon/Oxytocin & Magnesium Sulfate Protocols
9.1 Postpartum Haemorrhage (PPH): Definition, 4Ts, Bimanual Compression & Medical Protocols
Key Takeaways Explain This Topic AI
Primary postpartum haemorrhage (PPH) is defined as blood loss of ≥500 mL from the genital tract within 24 hours of birth, stratified into minor (500–1000 mL) and major (>1000 mL or signs of clinical shock).
The aetiology of PPH is classified by the 4Ts: Tone (uterine atony, 70–80%), Trauma (lacerations and rupture, ~20%), Tissue (retained placenta or membranes, ~10%), and Thrombin (coagulopathies, <1%).
First-line emergency management requires immediate escalation via the emergency buzzer and calling the 2222 obstetric emergency team, high-flow oxygen (15 L/min via reservoir mask), two 14G cannulae, and blood sampling for crossmatch and clotting.
Mechanical interventions must be initiated immediately: continuous fundal massage, bimanual uterine compression (Hamilton manoeuvre), and Foley bladder catheterisation.
RCOG GTG52 lists oxytocin 5 IU slow IV (repeatable) then 40 IU at 125 mL/h, ergometrine 500 mcg, carboprost 250 mcg IM up to 8 doses, misoprostol 800 mcg, and tranexamic acid 1 g IV.
Last updated: October 2026
Postpartum Haemorrhage (PPH): Definition, 4Ts, Bimanual Compression & Medical Protocols
Postpartum haemorrhage (PPH) remains one of the leading direct causes of maternal morbidity and mortality worldwide and across the United Kingdom. Rapid recognition, structured multidisciplinary communication, and swift execution of mechanical, pharmacological, and surgical interventions are essential competencies tested in the NMC Midwifery Test of Competence. Practice in the UK is governed by the Royal College of Obstetricians and Gynaecologists (RCOG) Green-top Guideline No. 52 ( Postpartum Haemorrhage: Prevention and Management ) .
Clinical Definitions & Classification of PPH
Postpartum haemorrhage is categorized by timing ( primary versus secondary ) and quantified by the estimated volume of blood loss alongside maternal clinical compromise.
Primary Postpartum Haemorrhage
Primary PPH is defined as the loss of ≥500 mL of blood from the genital tract occurring within 24 hours of birth .
In accordance with national UK guidelines, primary PPH is clinically stratified into:
Minor PPH : Cumulative blood loss of 500 mL to 1,000 mL without clinical signs of shock.
Major PPH : Cumulative blood loss of >1,000 mL , or any volume of bleeding accompanied by maternal cardiovascular compromise or clinical shock. Major PPH is further subdivided into:
Moderate Major PPH : Blood loss of 1,001 mL to 2,000 mL.
Severe / Massive Major PPH : Blood loss exceeding 2,000 mL, or bleeding associated with profound haemodynamic instability.
Important
Clinical estimation of blood loss by visual inspection notoriously underestimates true blood volume loss by 30% to 50% . Midwives must utilize objective, quantitative measurement techniques—including direct gravimetric weighing of all blood-soaked swabs, inco-pads, and drapes (1 gram = 1 mL of blood), and calibrated collection drapes—to prevent diagnostic delays. Furthermore, healthy pregnant women possess expanded plasma volumes (up to 45% above non-pregnant baselines) and can compensate haemodynamically until up to 1,000–1,500 mL of blood is lost before exhibiting classical hypotension. Tachycardia, tachypnoea, narrowed pulse pressure, and delayed capillary refill (>2 seconds) are earlier, critical warnings of hypovolaemia.
Secondary Postpartum Haemorrhage
Secondary PPH is defined as excessive, abnormal, or prolonged vaginal bleeding occurring between 24 hours and 12 weeks postpartum (RCOG). It is most commonly triggered by endometritis (pelvic infection) or retained placental tissue or membranes , frequently presenting in the community with subinvolution of the uterus, pyrexia, pelvic pain, and offensive lochia.
The 4Ts Aetiological Framework
When managing PPH, midwives utilize the mnemonic of the 4Ts to systematically diagnose and treat the underlying source of bleeding:
Aetiological Category Underlying Pathophysiological Causes Clinical Incidence Distinctive Clinical Signs
Tone (Uterine Atony) Failure of myometrial smooth muscle contraction and retraction. Risk factors: uterine overdistension (polyhydramnios, multiple pregnancy, macrosomia), prolonged labour, grand multiparity, chorioamnionitis, full bladder, tocolytic agents, halogenated general anaesthesia. 70%–80% Soft, boggy, poorly contracted uterus; fundal height above the umbilicus; continuous dark or brisk bright red bleeding.
Trauma (Genital Tract Lacerations) Cervical tears, vaginal wall lacerations, extended perineal trauma (OASIS: 3rd/4th degree tears), paravaginal or broad ligament haematoma, uterine rupture, uterine inversion. ~20% Persistent, brisk, bright red vaginal bleeding despite a firmly contracted ("rock-hard") uterine fundus; acute pelvic pain; expanding perineal swelling.
Tissue (Retained Products) Retained placental lobes (cotyledons), succenturiate placental lobe, retained membranes, morbidly adherent placenta (placenta accreta, increta, percreta). ~10% Missing cotyledon on placental examination, ragged membranes, persistent atony unresponsive to first-line uterotonics.
Thrombin (Coagulopathies) Pre-existing coagulopathies (von Willebrand disease, haemophilia carrier, immune thrombocytopenia) or acquired consumptive coagulopathy / Disseminated Intravascular Coagulation (DIC) secondary to placental abruption, amniotic fluid embolism (AFE), severe pre-eclampsia / HELLP syndrome, or massive transfusion. <1% Blood failing to clot in collection receptacles, oozing from intravenous cannulation sites, haematuria, petechiae, spontaneous mucosal bleeding.
Step-by-Step Emergency Resuscitation Protocol
Management of major PPH requires rapid, simultaneous execution of communication, clinical assessment, resuscitation, and source control. ┌──────────────────────────────────────────────┐
- │ PRIMARY PPH ESCALATION PROTOCOL │
- └──────────────────────┬───────────────────────┘
- │
- ┌──────────────────┬──────────────┴─────┬──────────────────┐
- ▼ ▼ ▼ ▼
- ┌─────────────────┐┌─────────────────┐┌─────────────────┐┌─────────────────┐
- │ CALL FOR HELP ││ ABCDE & AIRWAY ││ CIRCULATION ││ MECHANICAL │
- │ ││ ││ ││ INTERVENTIONS │
- │ • Emergency bell││ • High-flow O2 ││ • 2x 14G cannula││ • Rub up fundus │
- │ • Call 2222 ││ (15 L/min NRB)││ • Bloods to lab ││ • Hamilton │
- │ • MDT alerted ││ • Target sats ││ • Warmed fluids ││ compression │
- │ (Obs, Anaesth,││ 94–98% ││ • Group & match ││ • Empty bladder │
- │ Blood Bank) ││ ││ (4–6 units) ││ (Foley in) │
- └─────────────────┘└─────────────────┘└─────────────────┘└─────────────────┘
- 1. Communication & Team Mobilization
Pull the emergency call bell immediately.
Dial the hospital emergency number ( 2222 across UK NHS trusts) and state clearly: "Obstetric Emergency, Major Obstetric Haemorrhage, Delivery Suite / Room Number."
The obstetric emergency team must be mobilized at once: duty obstetric registrar, consultant obstetrician, duty anaesthetist, operating department practitioner (ODP), senior coordinating midwife, blood transfusion laboratory biomedical scientist, and hospital portering staff.
Appoint a dedicated scribe to record timestamps, vital signs, administered medications, and cumulative blood loss.
2. Airway, Breathing & Oxygenation
Assess airway patency and administer high-flow oxygen at 15 L/min via a non-rebreathe mask with reservoir bag , titrating to maintain maternal oxygen saturations between 94% and 98% .
3. Circulation & Intravenous Access
Establish two wide-bore intravenous cannulae (preferentially 14-gauge orange or 16-gauge grey) into prominent antecubital veins.
Immediately draw urgent baseline laboratory bloods:
- Full Blood Count (FBC) (haemoglobin and platelet count);
- Clotting Screen (Prothrombin Time [PT], Activated Partial Thromboplastin Time [APTT], and Fibrinogen level );
- Group and Crossmatch 4 to 6 units of packed red blood cells;
- Urea & Electrolytes (U&Es) and Liver Function Tests (LFTs);
Venous or Arterial Blood Gas (VBG/ABG) for bedside assessment of lactate, haemoglobin, base deficit, and ionised calcium.
Initiate rapid intravenous fluid resuscitation with up to 2,000 mL of warmed isotonic crystalloid (e.g. Hartmann's solution or 0.9% sodium chloride). If bleeding persists and crossmatched blood is not yet available, administer Group O RhD-negative uncrossmatched blood from the satellite emergency fridge without delay.
Mechanical Interventions: Fundal Massage, Bimanual Compression & Catheterisation
Before or simultaneously with pharmacological administration, physical measures must be applied to mechanically compress the myometrial vascular bed:
Uterine Fundal Massage : Place a cupped hand firmly onto the maternal fundus and perform continuous circular rubbing motions ("rubbing up a contraction") to stimulate endogenous prostaglandin release and muscular contraction.
Bimanual Uterine Compression (Hamilton Manoeuvre) :
Cleanse the perineum with antiseptic solution and don sterile gloves.
Form a firm fist with the dominant gloved hand and introduce it into the vagina, positioning the knuckles against the anterior vaginal fornix, pressing against the anterior uterine wall.
Place the other hand externally over the maternal abdominal wall onto the posterior aspect of the uterine fundus.
Compress the uterine corpus firmly between the internal vaginal fist and external abdominal hand, forcing the anterior and posterior uterine walls together. This directly compresses the bleeding placental bed vessels against each other, stemming arterial flow while medical therapies take effect.
Indwelling Bladder Catheterisation :
Insert a Foley catheter with a dedicated urometer .
A distended urinary bladder displaces the uterus superiorly and laterally, mechanically obstructing myometrial contraction and atony resolution.
Catheterisation empties the bladder immediately and allows strict hourly monitoring of urinary output, serving as an indispensable indicator of renal perfusion and end-organ resuscitation (target ≥0.5 mL/kg/hr or ≥30 mL/hr).
Pharmacological Uterotonic Ladder & Tranexamic Acid
When uterine atony is diagnosed or suspected, the midwife and obstetric team must administer uterotonic medications sequentially according to the evidence-based clinical ladder:
Step / Drug Dose & Route of Administration Mechanism & Onset Absolute Contraindications & Key Precautions
1. Oxytocin (Syntocinon) 5 IU by slow IV injection (RCOG GTG52; may be repeated). Followed by continuous IV infusion: 40 IU in 500 mL 0.9% NaCl running at 125 mL/hr (delivering 10 IU/hr) via an infusion pump. Stimulates oxytocin receptors in myometrium, generating rhythmic contractions. Rapid onset (1 minute IV). Rapid IV push can trigger transient hypotension, flushing, and reflex tachycardia. Avoid fluid overload / water intoxication from prolonged high-dose infusions.
2. Ergometrine 500 mcg (0.5 mg) IM or slow IV over 1–2 minutes. (Frequently co-administered with oxytocin as Syntometrine 5 IU/500 mcg IM in prophylactic settings). Ergot alkaloid inducing sustained, tetanic uterine and peripheral arterial smooth muscle contraction. ABSOLUTE CONTRAINDICATION: Pre-eclampsia, gestational hypertension, chronic hypertension, or severe cardiac disease. Can provoke catastrophic hypertensive crises, stroke, or myocardial ischaemia.
3. Carboprost (Hemabate / 15-methyl PGF2α) 250 mcg (0.25 mg) deep IM (or direct intramyometrial injection by obstetrician). May be repeated every 15 minutes up to a maximum of 8 doses (total 2.0 mg). Potent prostaglandin F2α analogue causing powerful prolonged myometrial contractions and vasoconstriction. ABSOLUTE CONTRAINDICATION: Active asthma or severe bronchospasm. Frequently causes severe bronchoconstriction, pyrexia, flushing, diarrhoea, nausea, and acute hypertension.
4. Misoprostol (PGE1 Analogue) 800 mcg sublingually or rectally (single dose). Synthetic prostaglandin E1 analogue; causes myometrial contractility. Readily absorbed via mucosal membranes. Known prostaglandin allergy. Adverse effects include shivering, rigors, and marked hyperpyrexia (temperature >40°C).
Adjunct: Tranexamic Acid (TXA) 1 g (1,000 mg) IV over 10 minutes (100 mg/mL). A second 1 g IV dose may be administered if bleeding continues after 30 minutes, or restarts within 24 hours. Antifibrinolytic; competitive inhibitor of plasminogen activation, preventing clot degradation. Best administered within 3 hours of birth (WOMAN trial demonstrated significant reduction in maternal mortality from bleeding without increasing thromboembolic risk). Caution in severe renal impairment.
Warning
Administering Ergometrine to a woman with hypertensive disease of pregnancy is a critical clinical error. Even in severe, life-threatening haemorrhage, Ergometrine must be withheld if the maternal blood pressure is elevated or if pre-eclampsia is diagnosed; alternative agents such as Carboprost (provided no asthma exists), Misoprostol, and Tranexamic Acid must be selected.
Intrauterine Balloon Tamponade & Surgical Escalation
If pharmacological uterotonics fail to arrest bleeding, the woman must be transferred immediately to the obstetric operating theatre for surgical interventions:
Examination Under Anaesthesia (EUA) : Direct visual inspection of the cervix, vagina, and perineum using broad Sims specula under optimal theatre lighting to exclude undetected high vaginal or cervical lacerations, alongside manual uterine exploration to remove any retained cotyledons or succenturiate lobes.
Intrauterine Balloon Tamponade (Bakri Balloon) :
A sterile silicone balloon catheter is inserted through the cervix into the uterine cavity.
The balloon is inflated with 300 mL to 500 mL of warmed sterile saline under direct ultrasound visualization until firm contact with the myometrial walls is achieved.
A "tamponade test" is considered positive if bleeding via the central drainage lumen ceases. The balloon exerts direct hydrostatic pressure against the endomyometrial venous sinuses. It is maintained under continuous oxytocin infusion coverage for 12 to 24 hours before gradual deflation.
Haemostatic Brace Sutures (B-Lynch Suture) : Compressive surgical suturing wrapping around the uterine fundus and lower segment, compressing the anterior and posterior walls together.
Vascular Ligation & Interventional Radiology : Bilateral uterine artery ligation, internal iliac (hypogastric) artery ligation, or selective percutaneous arterial embolization.
Peripartum Emergency Hysterectomy : The definitive, life-saving intervention of last resort for intractable haemorrhage refractory to all conservative surgical measures.
Activation of the Major Haemorrhage Protocol (MHP)
When blood loss exceeds 1,000 mL with active uncontrolled bleeding, or when haemodynamic shock ensues, the midwife or team leader activates the hospital Major Haemorrhage Protocol (MHP) by contacting the blood transfusion laboratory:
Blood Products (RCOG GTG52) : Red cells are given first, using O RhD-negative or group-specific blood in an emergency. If bleeding continues after 4 units of red cells and coagulation results are not yet available, 4 units of fresh frozen plasma are given; thereafter FFP and fibrinogen replacement are guided by laboratory or point-of-care tests. Platelets are given if the count falls below 75 × 10⁹/L . Obstetric protocols are therefore test-guided rather than a fixed 1:1:1 trauma ratio.
Fibrinogen Replacement : Normal pregnancy fibrinogen levels are elevated (4.0–6.0 g/L). A fibrinogen level falling below 2.0 g/L is an ominous predictor of catastrophic coagulopathy and DIC, warranting immediate infusion of Cryoprecipitate (typically two pools of 5 units) or Fibrinogen Concentrate .
Calcium Maintenance : Massive transfusion with citrated blood products chelates ionized calcium, impairing coagulation and myocardial contractility; 10 mL of 10% Calcium Gluconate IV is administered every 4 units of blood products.
Point-of-Care Coagulation : Utilization of Rotational Thromboelastometry (ROTEM) or Thromboelastography (TEG) allows rapid, goal-directed guided transfusion within 10–15 minutes.